Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration

Cornea

Volumn 26, Issue 9, 2007, Pages 1087-1089

  French, Dustin D ^a,b   Margo, Curtis E ^a  

^a James A Haley Veterans Hospital   (United States)

^b VISN 8 Patient Safety Center   (United States)

Author keywords

Amantadine; Corneal edema; Drug safety; Fuchs dystrophy

Indexed keywords

AMANTADINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA EDEMA; DIAGNOSTIC PROCEDURE; DRUG SAFETY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; AMANTADINE; ANTIPARKINSON AGENTS; ANTIVIRAL AGENTS; CORNEAL EDEMA; DATABASES, FACTUAL; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; HUMANS; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS, DRUG; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 34748881194     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181450d4c     Document Type: Article

References (11)

1. Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis. 2006;194(Suppl 2):S119-S126.
2. Shults CW. Treatments of Parkinson disease: circa 2003. Arch Neurol. 2003;60:1680-1684.
3. Blanchard DL. Amantadine caused corneal edema. Cornea. 1990;9:181.
4. Hughes B, Feiz V, Flynn SB, et al. Reversible amantadine-induced corneal edema in an adolescent. Cornea. 2004;23:823-824.
5. Galor A, Jeng BH, Lowder CY. A curious case of corneal edema. Eye Net. 2007;41-42.
6. Fraunfelder FT, Fraunfelder FW. Drug-Induced Ocular Side Effects. 5th ed. Boston, MA: Butterworth Heinemann; 2001.
7. French DD, Campbell R, Spehar A, et al. Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging. 2005;22:877-885.
8. Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol. 2007;143:538-539.
9. French DD, Spehar A, Campbell R, et al. A medication surveillance system model to improve patient safety: a national Veterans study of cyclooxygenase 2 inhibitors and risks of stroke or myocardial infarction. J Patient Safety. 2006;2:78-82.
10. Fraunfelder FW, Fraunfelder FT. Scientific challenges in postmarketing surveillance of ocular adverse drug reaction. Am J Ophthalmol. 2007;143:145-149.
11. Brunton LL, ed. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed., New York: McGraw-Hill; 2006.